Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset.

about

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset.

Item

http://www.wikidata.org/entity/Q54975650

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Real-world effectiveness and s ...... ed on a German claims dataset.

@en

Real-world effectiveness and s ...... ed on a German claims dataset.

@nl

type

Item

label

Real-world effectiveness and s ...... ed on a German claims dataset.

@en

Real-world effectiveness and s ...... ed on a German claims dataset.

@nl

prefLabel

Real-world effectiveness and s ...... ed on a German claims dataset.

@en

Real-world effectiveness and s ...... ed on a German claims dataset.

@nl

P1476

Real-world effectiveness and s ...... ed on a German claims dataset.

@en

P2093

Antje Groth

http://www.w3.org/2001/XMLSchema#string

Sabrina Mueller

http://www.w3.org/2001/XMLSchema#string

Stefan G Spitzer

http://www.w3.org/2001/XMLSchema#string

Ulf Maywald

http://www.w3.org/2001/XMLSchema#string

P2860

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups

New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial.

Discovery of anticoagulant drugs: a historical perspective.

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.

Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort stu

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/POR.S156521

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Pfaff

Anja Schramm

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29750067

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

atrial fibrillation

P932

5935078

http://www.w3.org/2001/XMLSchema#string